Skip to main content
Judith Soberman, MD, Cardiology, Memphis, TN

JudithESobermanMDMHA, FACC, FHRS, CCDS

Cardiology Memphis, TN

Cardiac Electrophysiology, Heart Failure & Transplantation, Non-Invasive Cardiology, Preventive Cardiology

Professor of Medicine, UT Health Science Center - Memphis Chief Medical Officer, Paradox Pharmaceuticals, Inc

Dr. Soberman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Soberman's full profile

Already have an account?

  • Office

    1910 Nonconnah Blvd
    Ste 120
    Memphis, TN 38132
    Phone+1 901-448-2300
    Fax+1 901-448-6657

Education & Training

  • University of Memphis
    University of MemphisMHA, Healthcare Administration, Honors, 2005 - 2009
  • Montefiore Medical Center/Albert Einstein College of Medicine (Montefiore)
    Montefiore Medical Center/Albert Einstein College of Medicine (Montefiore)Fellowship, Cardiovascular Disease, 1985 - 1988
  • Jacobi Medical Center/Albert Einstein College of Medicine
    Jacobi Medical Center/Albert Einstein College of MedicineResidency, Internal Medicine, 1982 - 1985
  • University of Pittsburgh School of Medicine
    University of Pittsburgh School of MedicineClass of 1982

Certifications & Licensure

  • TN State Medical License
    TN State Medical License 1988 - 2025
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

  • Fellow Heart Rhythm Society, 2009
  • Fellow (FACC) American College of Cardiology

Publications & Presentations

PubMed

Professional Memberships

Industry Relationships

  • Chief Medical Officer, Paradox Pharmaceuticals, IncParadox is a start up pharmaceutical company that endeavors to develop unique oncologic agents that are non-cardiotoxic.2010 - 2014